Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,375 hedge funds and large institutions have $71B invested in Celgene Corp in 2016 Q4 according to their latest regulatory filings, with 183 funds opening new positions, 493 increasing their positions, 545 reducing their positions, and 64 closing their positions.
186% more first-time investments, than exits
New positions opened: 183 | Existing positions closed: 64
41% more funds holding in top 10
Funds holding in top 10: 83 → 117 (+34)
12% more capital invested
Capital invested by funds: $63.3B → $71B (+$7.72B)
8% more funds holding
Funds holding: 1,278 → 1,375 (+97)
8% less call options, than puts
Call options by funds: $1.19B | Put options by funds: $1.28B
10% less repeat investments, than reductions
Existing positions increased: 493 | Existing positions reduced: 545
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
+$216M |
| 2 |
JP Morgan Chase
New York
|
+$204M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$182M |
| 4 |
HM
HealthCor Management
New York
|
+$151M |
| 5 |
SHCM
Sachem Head Capital Management
New York
|
+$150M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$216M |
| 2 |
VAM
Vontobel Asset Management
New York
|
-$209M |
| 3 |
Two Sigma Investments
New York
|
-$189M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$185M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
-$185M |
CELG Hedge Fund Activity: Q4 2016 in Review
1,375 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q4 2016, worth a combined $71B — up 12% from $63.3B a quarter earlier.
Buyers outnumbered sellers: 183 funds opened new CELG positions and 64 closed out — a net gain of 119 holders — while 493 added to existing stakes and 545 trimmed.
The largest buyer was VOYA Investment Management, adding an estimated $216M. The largest seller was Fidelity Investments, cutting an estimated $216M.
- 1,375 institutional investors held Celgene Corp (CELG) as of Q4 2016, up from 1,278 in Q3 2016.
- Funds reported $71B of Celgene Corp stock for Q4 2016, up 12% quarter-over-quarter.
- 183 funds opened new Celgene Corp positions in Q4 2016 and 64 closed out, a net change of +119 holders.
- The largest Celgene Corp buyer in Q4 2016 was VOYA Investment Management, an estimated $216M added.
- The largest Celgene Corp seller in Q4 2016 was Fidelity Investments, an estimated $216M sold.
Based on aggregated 13F filings for Q4 2016.